Target intelligence / Profile preview

Syndecan binding protein pseudogene 3 (SDCBPP3)

Target
SDCBPP3
Molecular classification
Pseudogene
01

Overview

Syndecan binding protein pseudogene 3 (SDCBPP3) is classified as a pseudogene in the human genome and does not produce a functional protein. It is named for its sequence similarity to the gene encoding syndecan binding protein (syntenin, SDCBP), a bona fide adaptor protein involved in cell signaling and membrane trafficking. However, unlike the protein-coding SDCBP gene, SDCBPP3 does not have known biological roles, does not serve as a receptor, and is not implicated in disease or drug targeting. There is no current evidence connecting SDCBPP3 to functional protein expression or therapeutic processes[1][2]. Key distinctions: - SDCBPP3 is a *pseudogene* and not a functional protein, enzyme, receptor, or drug target[1][2]. - It has *no known biological, physiological, or pharmacological role* and is not used as a therapeutic or diagnostic target. SDCBP (syntenin), in contrast, is a functional protein-coding gene with several biological roles and is sometimes studied in the context of cancer and signaling pathways[5][7][9]. However, SDCBPP3 is distinct and does not code for this protein.

Other names
Syndecan binding protein (syntenin) pseudogene 3SDCBPP3

Beyond the preview

Go deeper on Syndecan binding protein pseudogene 3 (SDCBPP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Syndecan binding protein pseudogene 3 (SDCBPP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call